PR

PSP Research Portfolio holdings

AUM $141M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$141M
AUM Growth
+$26.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$35.6M
2
+$6.17M
3
+$555K
4
GLUE icon
Monte Rosa Therapeutics
GLUE
+$535K
5
ARDX icon
Ardelyx
ARDX
+$529K

Top Sells

1
+$584K
2
+$554K
3
+$552K
4
BLTE
Belite Bio
BLTE
+$551K
5
APLS
Apellis Pharmaceuticals
APLS
+$549K

Sector Composition

1 Healthcare 24.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGOV icon
1
iShares 0-3 Month Treasury Bond ETF
SGOV
$90.9B
$70.5M 49.86%
700,000
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$8.4B
$36.4M 25.75%
+284,900
SERA icon
3
Sera Prognostics
SERA
$85.8M
$4.87M 3.44%
+2,396,685
DFTX
4
Definium Therapeutics
DFTX
$2.57B
$658K 0.47%
34,800
-41
TYRA icon
5
Tyra Biosciences
TYRA
$1.97B
$613K 0.43%
16,000
-5,853
ASND icon
6
Ascendis Pharma A/S
ASND
$14.5B
$572K 0.4%
2,500
-79
PHVS icon
7
Pharvaris
PHVS
$2.06B
$565K 0.4%
20,000
-511
CYTK icon
8
Cytokinetics
CYTK
$10.5B
$547K 0.39%
8,300
-13
RPRX icon
9
Royalty Pharma
RPRX
$23.9B
$528K 0.37%
11,000
-2,826
KYMR icon
10
Kymera Therapeutics
KYMR
$6.72B
$525K 0.37%
6,300
-48
HALO icon
11
Halozyme
HALO
$8.14B
$519K 0.37%
8,026
EXEL icon
12
Exelixis
EXEL
$12.6B
$512K 0.36%
11,948
IRON icon
13
Disc Medicine
IRON
$2.66B
$512K 0.36%
+8,000
IONS icon
14
Ionis Pharmaceuticals
IONS
$12.6B
$511K 0.36%
6,800
AGIO icon
15
Agios Pharmaceuticals
AGIO
$1.7B
$507K 0.36%
+15,000
NBIX icon
16
Neurocrine Biosciences
NBIX
$15.7B
$507K 0.36%
3,848
+114
INCY icon
17
Incyte
INCY
$19.4B
$499K 0.35%
5,300
-50
TARS icon
18
Tarsus Pharmaceuticals
TARS
$2.58B
$491K 0.35%
7,000
+481
VKTX icon
19
Viking Therapeutics
VKTX
$3.68B
$488K 0.35%
15,000
+286
ALNY icon
20
Alnylam Pharmaceuticals
ALNY
$39.5B
$485K 0.34%
1,465
+147
PRAX icon
21
Praxis Precision Medicines
PRAX
$9.96B
$483K 0.34%
1,500
-482
AXSM icon
22
Axsome Therapeutics
AXSM
$12.1B
$481K 0.34%
+2,845
NAMS icon
23
NewAmsterdam Pharma
NAMS
$4.27B
$480K 0.34%
15,000
+80
ARDX icon
24
Ardelyx
ARDX
$1.52B
$479K 0.34%
+80,000
IMVT icon
25
Immunovant
IMVT
$6.86B
$477K 0.34%
19,200
-1,105
1
2 3 4 5